|Other Names||Dopamine beta-hydroxylase, Dopamine beta-monooxygenase, Soluble dopamine beta-hydroxylase, DBH|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Conversion of dopamine to noradrenaline.|
|Cellular Location||Soluble dopamine beta-hydroxylase: Cytoplasmic vesicle, secretory vesicle lumen. Cytoplasmic vesicle, secretory vesicle, chromaffin granule lumen Secreted|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The protein encoded by this gene is an oxidoreductasebelonging to the copper type II, ascorbate-dependent monooxygenasefamily. It is present in the synaptic vesicles of postganglionicsympathetic neurons and converts dopamine to norepinephrine. Itexists in both soluble and membrane-bound forms, depending on theabsence or presence, respectively, of a signal peptide. [providedby RefSeq].
Fernandez-Castillo, N., et al. Psychiatr. Genet. 20(6):317-320(2010)Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Ruano, G., et al. Pharmacogenomics 11(7):959-971(2010)Punia, S., et al. Pharmacogenet. Genomics 20(7):435-441(2010)Pinheiro, A.P., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (5), 1070-1080 (2010) :
If you have any additional inquiries please email technical services at email@example.com.